Neurocrine Biosciences



Ebitda Veränderung Datum
AbbVie USD 6.92B 258M 2024-12
Acadia Pharmaceuticals USD 22.24M 10.04M 2025-03
Agios Pharmaceuticals USD -105351000 18.32M 2025-03
ALKERMES USD 21.21M 142.21M 2025-03
Alnylam Pharmaceuticals USD 32.48M 123.47M 2025-03
Amgen USD 3.75B 42M 2025-03
Biogen USD 754.8M 7.2M 2024-12
BioMarin Pharmaceutical USD 245.96M 51.11M 2025-03
Cytokinetics USD -153331000 16.67M 2025-03
Dynavax Technologies USD -21594000 22.03M 2025-03
Exelixis USD 194.2M 23.1M 2025-04
Gilead Sciences USD 3.21B 651M 2024-12
Halozyme Therapeutics USD 162M 33.97M 2025-03
Incyte USD 222.66M 97.54M 2025-03
Ionis Pharmaceuticals USD -141463000 35.91M 2025-03
Neurocrine Biosciences USD 152.1M 39.2M 2024-12
Pfizer USD 6.21B 1.5B 2025-03
Prothena USD -64676000 1.61M 2024-12
Regeneron Pharmaceuticals USD 730.9M 324.8M 2025-03
Repligen USD 22.82M 6.41M 2025-03
Sarepta Therapeutics USD -290408000 472.62M 2025-03
Teva Pharmaceutical Industries USD 1.11B 848M 2025-03
Ultragenyx Pharmaceutical USD -113199000 10.03M 2024-12
Vertex Pharmaceuticals USD 1.16B 24.5M 2024-12



Neurocrine Biosciences - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.